Canadian Journal of Public Health

, Volume 96, Issue 3, pp 197–200 | Cite as

Varicella Vaccination for Grades 4 and 5 Students

From Theory to Practice
  • Paul RivestEmail author
  • Lise Grenier
  • Guy Lonergan
  • Lucie Bédard



In 2002–2003, as part of a pilot project, varicella vaccination was offered to susceptible students in grades 4 and 5 in schools whose health services are provided by a local community services centre in Montréal. This immunization campaign was merged with the hepatitis B immunization programme.


To calculate the proportion of grade 4 and 5 students susceptible to varicella; to calculate the proportion of susceptible students who agree to be vaccinated; to compare the proportion of susceptibles who agree to be vaccinated when varicella vaccination is offered with the first or the second dose of hepatitis B; and to assess whether a catch-up varicella immunization programme would affect the vaccine coverage of a concurrent hepatitis B vaccination programme.


The proportions of susceptible students and of parents of susceptibles who consented to vaccination were calculated. The proportions of parents of susceptibles who consented to vaccination were compared for both immunization strategies: varicella vaccination given with the first or second dose of hepatitis B vaccine. Logistic regression was performed to identify possible associations between consent to varicella vaccination and the various variables collected. Rates of vaccine coverage against hepatitis B after two doses were compared for the years 2000–2001 and 2002–2003.


Of 3,856 registered students, 3,486 (90.4%) returned consent forms. Among the 3,272 students for whom information was available, 441 (13.5%) were susceptible, including 394 (89.3%) who consented to vaccination. The rates of vaccine coverage in the schools after two doses of hepatitis B vaccine were exactly the same for the 2000–2001 and 2002–2003 school years.


Varicella vaccination of susceptible grade 4 and 5 students associated with a coincident hepatitis B vaccination campaign can be performed without negative impact on the hepatitis B vaccination programme.

MeSH terms

Chickenpox immunization vaccination hepatitis B school 



En 2002–2003, la vaccination contre la varicelle a été offerte aux élèves susceptibles de 4e et de 5e année des écoles situées sur le territoire d’un centre local de services communautaires de Montréal. Cette campagne de vaccination était intégrée au programme de vaccination contre l’hépatite B.


1) Calculer la proportion d’élèves de 4e et de 5e année sensibles à la varicelle; 2) calculer la proportion d’élèves sensibles qui acceptent d’être vaccinés; 3) comparer la proportion d’élèves sensibles qui acceptent d’être vaccinés en fonction du moment où est offerte la vaccination contre la varicelle; et 4) évaluer l’effet d’une campagne de rattrapage pour la varicelle sur le taux de couverture vaccinale du programme régulier de vaccination contre l’hépatite B.


La proportion d’enfants sensibles et la proportion de parents d’enfants sensibles qui ont consenti à la vaccination ont été calculées. Les proportions de parents d’élèves sensibles ayant consenti à la vaccination ont été comparées en fonction des deux stratégies de vaccination: l’administration du vaccin contre la varicelle soit avec la première, soit avec la seconde dose du vaccin contre l’hépatite B. Par régression logistique, nous avons cerné les associations possibles entre le consentement à la vaccination contre la varicelle et les différentes variables recueillies. Le taux de couverture vaccinale contre l’hépatite B après deux doses a été comparé pour les années 2000–2001 et 2002–2003.


Sur 3 856 élèves inscrits, 3 486 (90,4 %) ont retourné un formulaire de consentement. Parmi les 3 272 élèves pour lesquels l’information était disponible, 441 (13,5 %) étaient sensibles. Parmi eux, 394 (89,3 %) ont consenti à la vaccination. La proportion d’élèves sensibles et la proportion d’élèves sensibles ayant consenti à la vaccination étaient comparables dans les deux groupes d’intervention.


Une vaccination contre la varicelle des élèves sensibles de 4e et de 5e année en association avec la campagne de vaccination contre l’hépatite B peut se faire sans impact négatif sur la campagne de vaccination contre l’hépatite B.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    National Advisory Committee on Immunization. Statement on recommended use of varicella vaccine. CCDR 1999;25(ACS-1):1–16.Google Scholar
  2. 2.
    Canadian Pediatric Society. Varicella vaccine for children. Paedriatr Child Health 2003;8(6):384.CrossRefGoogle Scholar
  3. 3.
    Skull SA, Wrang EEL. Varicella vaccination: Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001;164:1388–89.Google Scholar
  4. 4.
    Health Canada. Proceedings of the National Varicella Consensus Conference. Montreal, Quebec, May 5–7, 1999. CCDR 1999;25S5:1–29.Google Scholar
  5. 5.
    Sweet L, Gallant P, Morris M, Halperin SA. Canada’s first universal varicella immunization program: Lessons from Prince Edward Island. Can J Infect Dis 2003;14(1):41–44.CrossRefPubMedGoogle Scholar
  6. 6.
    National Advisory Committee on Immunization. Update on varicella. CCDR 2004;30(ACS-1):1–26.Google Scholar
  7. 7.
    Halloran ME, Cochi S, Lieu TA, Wharton M, Fehrs L. Theoretical epidemiologic and morbidity effects of routine immunization of pre-school children with live-virus varicella vaccine in the US. Am J Epidemiol 1994;140:81–104.CrossRefGoogle Scholar
  8. 8.
    Rivest P, Bédard L, Valiquette L, Mills E, Lebel MH, Lavoie G, et al. Severe complications associated with varicella: Province of Quebec, April 1994 to March 1996. Can J Infect Dis 2001;12(1):21–26.CrossRefPubMedGoogle Scholar
  9. 9.
    Centers for Disease Control and Prevention. Prevention of varicella; recommendations of the Advisory Committe on Immunization Practices (ACIP). MMWR 1996;45(No RR-11):1–36.Google Scholar
  10. 10.
    Boulianne N, Duval B, De Serres G, Deceuninck G, Massé R, Couillard M. Most ten-year-old children with negative or unknown histories of chickenpox are immune. Pediatr Infect Dis J. 2001;20(11):1087–88.CrossRefGoogle Scholar
  11. 11.
    Finger R, Hughes JP, Meade BJ, Pelletier AR, Palmer CT. Age-specific incidence of chicken-pox. Public Health Rep 1994;109(6):7500–55.Google Scholar
  12. 12.
    Daniel WW. Biostatistics - A Foundation for Analysis in the Health Sciences, 6th edition. New York, NY: John Wiley & Sons, Inc., 1995;18081.Google Scholar
  13. 13.
    Taylor JA, Cufley D. The association between parental health beliefs and immunization status among children followed by private pediatricians. Clin Pediatr 1996;35(1):18–22.CrossRefGoogle Scholar
  14. 14.
    Schaffer SJ, Bruno S. Varicella immunization practices and the factors that influence them. Arch Pediatr Adolesc Med 1999;153(4):357–62.CrossRefGoogle Scholar
  15. 15.
    de Courval FP, De Serres G, Duval B. Varicella vaccine: Factors influencing uptake. Can J Public Health 2003;94(4):268–71.Google Scholar
  16. 16.
    Boulianne N, Duval B, De Serres G, Deceuninck G, Dionne M, Carsley J, et al. Opinions of Québec parents and vaccinators on the usefulness of chickenpox vaccine. Can J Infect Dis 2001;12(3):153–56.CrossRefPubMedGoogle Scholar
  17. 17.
    Robert Y, Béliveau C, Boucher M, Boulianne N, Tapiero B, Tremblay M, et al. Rapport sur l’utilisation d’un vaccin contre la varicelle au Québec. Québec: Institut national de santé publique du Québec, 2000;195.Google Scholar

Copyright information

© The Canadian Public Health Association 2005

Authors and Affiliations

  • Paul Rivest
    • 1
    • 2
    Email author
  • Lise Grenier
    • 1
  • Guy Lonergan
    • 1
    • 1
  • Lucie Bédard
    • 1
    • 2
  1. 1.Direction de santé publique de Montréal-CentreMontréalCanada
  2. 2.Département de médecine sociale et préventiveUniversité de MontréalMontréalCanada

Personalised recommendations